| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/30/2006 | US20060069121 N-(3-{[1-(dimethylamino)-2-nitrovinyl]amino}phenyl)-3-[(quinolin-4-ylmethyl)amino]thiophene-2-carboxamide; neuroblastoma, mast cell leukemia, angiosarcoma, anaplastic large cell lymphoma, endometrial carcinoma, and prostate carcinoma |
| 03/30/2006 | US20060069120 Novel piperidine derivaties as modulators of chemokine receptor ccr5 |
| 03/30/2006 | US20060069119 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 03/30/2006 | US20060069118 Crystalline forms of a factor Xa inhibitor |
| 03/30/2006 | US20060069117 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 03/30/2006 | US20060069116 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/30/2006 | US20060069115 Use of pde4 inhibitors as adjunct therapy for psychiatric disorders |
| 03/30/2006 | US20060069114 Liquid pharmaceutical formulations of palonosetron |
| 03/30/2006 | US20060069113 Analgesic compositions containing buprenorphine |
| 03/30/2006 | US20060069112 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/30/2006 | US20060069111 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome |
| 03/30/2006 | US20060069110 Antiinflamamtory agents; cardiovascular disorders; brain disorders; antiarthritic agents; antidiabetic agents; antiallergens; leukemia; adult respirartory distress syndrome; Crohn's disease |
| 03/30/2006 | US20060069109 Therapeutic agents |
| 03/30/2006 | US20060069108 Use of (R)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
| 03/30/2006 | US20060069107 Method of treating behavioral disorders |
| 03/30/2006 | US20060069106 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 03/30/2006 | US20060069105 Protein tyrosine kinase inhibitors |
| 03/30/2006 | US20060069104 Neurotrophic factor production accelerator |
| 03/30/2006 | US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 03/30/2006 | US20060069102 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease |
| 03/30/2006 | US20060069101 Prodrugs of protein tyrosine kinase inhibitors |
| 03/30/2006 | US20060069100 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 03/30/2006 | US20060069099 Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 03/30/2006 | US20060069098 Bone disorders; reduce concentration of parathyroid hormone in blood |
| 03/30/2006 | US20060069097 N-[3-(trifluoromethyl)phenyl]-4-{2-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-b]pyridazin-3-yl}pyrimidin-2-amine; enzyme inhibitors; inhibition/antagonism of protein kinases, glycogen synthase kinase-3-beta; central nervous system disorders; Alzheimer's disease; bipolar disorder; stroke; anticarcinogenic |
| 03/30/2006 | US20060069096 Pyrazolo[3,4-e]benzoxazoles for the treatment of glaucoma |
| 03/30/2006 | US20060069095 Azole derivatives |
| 03/30/2006 | US20060069094 (7-Phenylsulfonyl-1,2,3,4-tetrahydro-naphthalen-1-ylmethyl)-(5,5-dimethyl-1,4,5,6-tetrahydro-pyrimidin-2-yl)-amine; 5-HT6 receptor/5-HT2A receptor antagonist; Alzheimer's disease |
| 03/30/2006 | US20060069093 Substituted 2H-1,3-benzoxazin-4(3H)-ones |
| 03/30/2006 | US20060069092 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 03/30/2006 | US20060069091 E.g., 2-[2-carboxypropyl]-5-hydroxy-1,2-oxazin-3-one, more potent than desacetoxycephalosporin G; bactericides reacting irreversibly with the active site serine residue of the enzyme; enzyme inhibitors; mimetics; isocephalosporins; monocyclic beta-lactam antibiotics; antibiotic resistance |
| 03/30/2006 | US20060069090 Triazine compounds |
| 03/30/2006 | US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 03/30/2006 | US20060069087 Histamine-3 receptor antagonists |
| 03/30/2006 | US20060069086 Methods for regulating neurotransmitter systems by inducing counteradaptations |
| 03/30/2006 | US20060069085 Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069082 Novel substituted thiophenecarboxamides, their preparation and their use as medicaments |
| 03/30/2006 | US20060069081 beta -methyl carbapenem compounds; for multiple-drug resistant bacterial strain |
| 03/30/2006 | US20060069080 Combinations of substituted azetidinones and CB1 antagonists |
| 03/30/2006 | US20060069079 Stable amorphous cefdinir |
| 03/30/2006 | US20060069078 long chain retinyl ketone; prevent retinotoxic accumulation; inhibits, antagonizes, or short-circuits the visual cycle at a step of the visual cycle that occurs outside a disc of a rod photoreceptor |
| 03/30/2006 | US20060069077 Receptor-type kinase modulators and methods of use |
| 03/30/2006 | US20060069076 LXR/RXR-related methods and compositions |
| 03/30/2006 | US20060069075 Methods for treating dry eye |
| 03/30/2006 | US20060069074 Genetic predictor of efficacy of anti-asthmatic agents for improving pulmonary function |
| 03/30/2006 | US20060069073 Medicaments for inhalation comprising steroids and an anticholinergic |
| 03/30/2006 | US20060069072 Method of male sexual enhancement |
| 03/30/2006 | US20060069071 Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations |
| 03/30/2006 | US20060069070 Treatment of fibrosis using FXR ligands |
| 03/30/2006 | US20060069069 Methods and compositions for the administration of calcium chelators, bisphosponates and/or citrate compounds and their pharmaceutical uses |
| 03/30/2006 | US20060069068 Methods and compositions for the treatment of diseases characterized by pathological calcification |
| 03/30/2006 | US20060069067 Combination of an aromatase inhibitor with a bisphosphonate |
| 03/30/2006 | US20060069066 3-(4-(3-guanidinophenyl)-1,2,3-triazol-1-yl)benzyl phosphoric acid hydrochloride; obesity, non-insulin dependent diabetes mellitus, insulin-dependent condition, affective disorder, neurodegenerative diseases, psychotic disease; compounds having hydrophobic moiety to a terminus of a peptide GSK-3 |
| 03/30/2006 | US20060069065 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 03/30/2006 | US20060069064 Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using hyaluronic acid |
| 03/30/2006 | US20060069063 Crosslinked polygalacturonic acid used for postsurgical tissue adhesion prevention |
| 03/30/2006 | US20060069062 toothpastes, mouthwashes, chewing gums, tableted candy, for inhibiting induction of dental caries |
| 03/30/2006 | US20060069061 Administering a choline and uridine 5-monophosphate; improving memory, learning, cognition, synaptic transmission, synthesis/release of neurotransmitters, and increasing brain phospholipid levels; Alzheimer's disease |
| 03/30/2006 | US20060069060 Salts of decitabine |
| 03/30/2006 | US20060069059 Topical formulations for the treatment of depression with S adenosyl methionine |
| 03/30/2006 | US20060069058 Beta-sheet breaker peptide analogs that inhibit beta-pleated sheet formation in amyloid beta-peptide |
| 03/30/2006 | US20060069057 Medicaments containing xenogeneic oligo- and/or polyribonucleotides |
| 03/30/2006 | US20060069048 synthetic macrolides useful in the treatment and prevention of bacterial infections |
| 03/30/2006 | US20060069047 Antibiotic conjugates |
| 03/30/2006 | US20060069046 Green tea extract ; for use in foods and supplements |
| 03/30/2006 | US20060069045 Methods for treating familial dysautonomia |
| 03/30/2006 | US20060069044 Modified glycosaminoglycans, pharmaceutical compositions and methods for oral delivery thereof |
| 03/30/2006 | US20060069043 Chiral separation, characterization and biological action of optically active isomers of digoxin |
| 03/30/2006 | US20060069042 Cytochrome P450 2C9 inhibitors |
| 03/30/2006 | US20060069041 Bioavailability; acid, amine, or polyhydroxy-functionalized; e.g. mono-[1-(4,8-dioxo-4,8-dihydrobenzo[1,2-b;5,4-b']dithiophen-2-yl)-methyl]succinate; antitumor agents; non-small cell lung cancer, breast cancer, nasopharynx carcinoma and prostate cancer |
| 03/30/2006 | US20060069040 GHB compositions |
| 03/30/2006 | US20060069039 Treatment of dyskinesia |
| 03/30/2006 | US20060069038 Irreversible caspase-3 inhibitors as active site probes |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060069036 Treating an inflammatory skin disorder by topically applying to the affected skin areas an effective amount of high concentration (40-60%) reduced glutathione; alpha lipoic acid as adjuvant and carrier; antiinflammatory agents; antiallergens; psoriasis; eczema; seborrhea dematitus; roazcea; acne |
| 03/30/2006 | US20060069034 Antipathogenic benzamide compounds |
| 03/30/2006 | US20060069033 Use of poly-amminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis |
| 03/30/2006 | US20060069031 use of agonist of hypothalamic hormone, i.e. GnRH, for preparation to support luteal phase during infertility treatment of female mammals; pharmaceutical agent supports luteal phase after spontaneous ovulation or after stimulation of follicular growth triggering final follicular maturation and ovulation |
| 03/30/2006 | US20060069028 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 03/30/2006 | US20060069018 Treating lung diseases selected from acute pneumonia, pulmonary fibrosis, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), and asthma by administering (E)-[5-[2-[1-phenyl-1-(3-pyridyl)methylideneaminoxy]ethyl]-7,8-dihydronaphthalen-1-yloxy]acetic acid or a salt thereof |
| 03/30/2006 | US20060069014 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 03/30/2006 | US20060069013 Pharmaceutical preparations comprising acid-stabilised insulin |
| 03/30/2006 | US20060068389 Methods and compositions for inhibiting hiv replication |
| 03/30/2006 | US20060068043 Aqueous solution of flavonoids and anthocyanins |
| 03/30/2006 | US20060068040 Carrier-free composition for the treatment of onychomycosis |
| 03/30/2006 | US20060068039 Composition for the treatment of gastrointestinal disorders |
| 03/30/2006 | US20060068038 Mixing with zinc gluconate/selenium, compressing and folding to form tablets containing tocopherols |
| 03/30/2006 | US20060068037 Admixing process for making compositions containing vitamin E and saw palmetto |
| 03/30/2006 | US20060068035 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 03/30/2006 | US20060068027 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 03/30/2006 | US20060068023 Chewable tablet containing lysine |
| 03/30/2006 | US20060068020 Encapsulated pharmaceutical agents |
| 03/30/2006 | US20060068016 Paticulate product comprising pantethine |
| 03/30/2006 | US20060068015 Particulate or in solid dosage forms; a combination of fibrate and HMG CoA reductase inhibitor statins or a pharmaceutically active salts, in dissolved form in order to ensure suitable bioavailability of both active ingredients upon oral administration |
| 03/30/2006 | US20060068007 Class of surfactant-like materials |
| 03/30/2006 | US20060068005 Chewable electrolyte tablet |
| 03/30/2006 | US20060067998 Liposomal curcumin for treatment of cancer |
| 03/30/2006 | US20060067997 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
| 03/30/2006 | US20060067983 Stand-alone film and methods for making the same |